Nautilus Biotechnology Inc (NASDAQ:NAUT) Stock is trading at a margin of 10.22% From 20-Day SMA
Morgan Stanley raised the price target for the Nautilus Biotechnology Inc (NASDAQ:NAUT) stock to “an Equal-weight”. The rating was released on January 06, 2022, according to finviz. The research report from Goldman has initiated the stock to Neutral, with a price target set at $10. The stock was initiated by Jefferies, who disclosed in a […]